HUTCHMED (China) HCM
NASDAQ HCM
$12.47 -0.12 (-0.95%)
At close: Aug 20, 2026 · 1:19 PM UTC

HUTCHMED (China) (HCM) Other Non Operating Income (2018 - 2019)

HUTCHMED (China) (HCM) posted quarterly Other Non Operating Income of $2.0 million for Q4 2019, up 8.74% year-over-year from $1.8 million in Q4 2018, and up 8.74% quarter-over-quarter from $1.8 million in Q4 2018.

HUTCHMED (China) (HCM) Other Non Operating Income (2018 - 2019) Analysis & Trends

HUTCHMED (China) (HCM) has reported Other Non Operating Income for 2 consecutive years, with $2.0 million the latest figure, recorded in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.91 Bn 42.95 Bn -
2 Teva Pharmaceutical Industries 43.07 Bn 39.42 Bn 2.15 Bn
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn
5 United Therapeutics 22.19 Bn 19.53 Bn 683.80 Mn
6 Viatris 18.68 Bn 17.79 Bn 1.46 Bn
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn -
10 HUTCHMED (China) 2.16 Bn 2.16 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2019 1.98 Mn
Dec 31, 2018 1.82 Mn
Sep 30, 2018 -3.21 Mn